Ryan Spencer

Ryan Spencer

Director Ejecutivo en DYNAVAX TECHNOLOGIES CORPORATION .

Fortuna: 3 M $ al 30/04/2024

46 años
Health Technology
Technology Services
Consumer Services

Origen de la red de primer grado Ryan Spencer.

EntidadTipo de entidadIndustria
221
Non-Profit Organization Miscellaneous Commercial Services 221
Public Company Biotechnology 68
Public Company Pharmaceuticals: Other 16

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Ryan Spencer a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
College/University

Jonathan Leff

Bruce W. Ferguson

N. Coles

Carlos Riva

Steven D. Singer

Bradley A. Shurdut

Undergraduate Degree

Masters Business Admin

Graduate Degree

Masters Business Admin

Graduate Degree

Graduate Degree

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Helen Torley

Jeremy Levin

N. Coles

Theodore Schroeder

James Sapirstein

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Rutgers State University of New Jersey College/University

Dan Kisner

Theodore Schroeder

John Orwin

James Sapirstein

Robert Repella

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Steven Paul

Dennis A. Carson

Julie Gerberding

Bonnie Bassler

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

AMGEN INC. Pharmaceuticals: Major

Fabrizio Bonanni

Helen Torley

Julia Eastland

Chrysa Mineo

Chief Operating Officer

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

Stanford University College/University

Richard Pops

Daniel Burgess

Carlos Riva

Robert Janssen

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Undergraduate Degree

NOVARTIS AG Pharmaceuticals: Major

David Pyott

Flemming Ørnskov

Ludwig Hantson

Brent MacGregor

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

Steven Paul

Edward O. Lanphier

James Sapirstein

Martin Babler

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Chief Operating Officer

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

Ted Love

James Sapirstein

Robert Janssen

Shane Ward

Director/Board Member

Sales & Marketing

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

Carl Feldbaum

Jeremy Levin

Edward O. Lanphier

Ted Love

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

SEAGEN INC. Pharmaceuticals: Major

Ted Love

Clay Siegall

John Orwin

Director/Board Member

Chief Executive Officer

Director/Board Member

Princeton University College/University

Carl Feldbaum

Ronald Cohen

Bonnie Bassler

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

ARBUTUS BIOPHARMA CORPORATION Pharmaceuticals: Major

Peggy Phillips

Dan Kisner

Daniel Burgess

Director/Board Member

Chairman

Director/Board Member

Miscellaneous Commercial Services

Steven Paul

Dennis A. Carson

Bonnie Bassler

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Richard Pops

Vaughn M. Kailian

David Meeker

Director/Board Member

Director/Board Member

Director/Board Member

The Trustees of Columbia University in The City of New York College/University

Jean-Francois Formela

Dennis A. Carson

David Novack

Masters Business Admin

Doctorate Degree

Masters Business Admin

Pharmaceuticals: Major

Helen Torley

Ted Love

N. Coles

Chief Operating Officer

Chief Tech/Sci/R&D Officer

Chief Executive Officer

Miscellaneous Commercial Services

Mitchell S. Bloom

Renee Connolly

Steven D. Singer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

N. Coles

Julie Gerberding

Donald P. Beeman

Corporate Officer/Principal

Public Communications Contact

Corporate Officer/Principal

Pharmaceuticals: Major

Steven Holtzman

Vaughn M. Kailian

John Maraganore

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Biotechnology

Ted Love

John Orwin

Martin Babler

General Counsel

Corporate Officer/Principal

Sales & Marketing

General Government

Steven Paul

Scott Koenig

Robert J. Beall

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Jean-Francois Formela

John Orwin

Chrysa Mineo

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Ludwig Hantson

Jeremy Springhorn

Steven Ryder

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Vaughn M. Kailian

David Stack

Andrew Hack

Private Equity Investor

Private Equity Investor

Private Equity Investor

MACROGENICS, INC. Pharmaceuticals: Major

Arnold Lewis Oronsky

John Maraganore

Scott Koenig

Director/Board Member

Chairman

Founder

SANOFI Biotechnology

David Meeker

Bonnie Bassler

Brent MacGregor

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

The Johns Hopkins University College/University

Jonathan Leff

N. Coles

Bonnie Bassler

Graduate Degree

Director/Board Member

Doctorate Degree

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Pyott

Steven Paul

John Maraganore

Director/Board Member

Director/Board Member

Chief Executive Officer

Miscellaneous Commercial Services

Daniel Burgess

Theodore Schroeder

Carin Canale-Theakston

Director/Board Member

Director/Board Member

Director/Board Member

ABBOTT LABORATORIES Medical Specialties

Dan Kisner

Shane Ward

Steven N. Gersten

Corporate Officer/Principal

Corporate Officer/Principal

Compliance Officer

Pharmaceuticals: Major

Richard Pops

Renee Connolly

Herve Hoppenot

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Miscellaneous Commercial Services

Dennis A. Carson

Hugh Grant

Bonnie Bassler

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

AFFYMAX, INC. Biotechnology

Ted Love

John Orwin

Director/Board Member

Chief Executive Officer

University of Glasgow College/University

Helen Torley

Hugh Grant

Undergraduate Degree

Undergraduate Degree

State University of New York at Albany College/University

Gregory Duncan

David Novack

Undergraduate Degree

Undergraduate Degree

SYROS PHARMACEUTICALS, INC. Biotechnology

Jonathan Leff

Jeremy Springhorn

Director/Board Member

Corporate Officer/Principal

RELYPSA INC Pharmaceuticals: Major

Helen Torley

John Orwin

Director/Board Member

Chief Executive Officer

HALOZYME THERAPEUTICS, INC. Biotechnology

Helen Torley

Elaine Sun

Chief Executive Officer

Director of Finance/CFO

College/University

Robert Ruffolo

David Meeker

Doctorate Degree

Corporate Officer/Principal

Pharmaceuticals: Major

Renee Connolly

James Sapirstein

Public Communications Contact

Corporate Officer/Principal

Miscellaneous Commercial Services

Theodore Schroeder

Jeffrey Stein

Chairman

Chairman

Columbia University College of Physicians & Surgeons College/University

Arnold Lewis Oronsky

Ronald Cohen

Doctorate Degree

Doctorate Degree

University of California, Berkeley College/University

Matthew Pfeffer

Julie Gerberding

Undergraduate Degree

Graduate Degree

Chemicals: Agricultural

Francis Cano

Arnold Lewis Oronsky

Corporate Officer/Principal

Corporate Officer/Principal

Haverford College College/University

Ted Love

Dennis A. Carson

Undergraduate Degree

Undergraduate Degree

Estadísticas

Internacional

Estados Unidos 46
Francia 3
Suiza 2
Bélgica 2
Reino Unido 2

Sectorial

Health Technology 27
Consumer Services 13
Commercial Services 9
Government 2
Finance 2

Operativa

Director/Board Member 739
Corporate Officer/Principal 275
Independent Dir/Board Member 197
Chairman 154
President 136
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA